Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
SLR Investment Corp.SLR Investment Corp. Reports Q3 2025 Financial Results with $21.6M Net Investment Income
NetBrands Corp.NetBrands Corp. Reports Q3 2025 Financial Results with Shift to Cryptocurrency Mining
TopBuild CorpTopBuild Reports Q3 2025 Financial Results with $142.2M Net Income
RIGEL PHARMACEUTICALS INCRigel Pharmaceuticals Reports 25.5% Revenue Growth to $69.5 Million in Q3 2025
RHYTHM PHARMACEUTICALS, INC.Rhythm Pharmaceuticals Reports 54% Revenue Growth in Q3 2025, Faces Increased Losses
Mirum Pharmaceuticals, Inc.Mirum Pharmaceuticals Reports $2.9 Million Net Income in Q3 2025, Up from Loss in 2024
Xometry, Inc.Xometry Reports 28% Revenue Growth to $180.7 Million in Latest Quarter
Jushi Holdings Inc.Jushi Holdings Reports Q3 2025 Revenue Growth to $65.7 Million Amid Increased Losses
TIGO ENERGY, INC.Tigo Energy Reports 115% Revenue Growth to $30.6 Million in Latest Quarter
Tempus AI, Inc.Tempus AI Reports 85% Revenue Growth to $334.2 Million in Q3 2025
Uber Technologies, IncUber Reports 20% Revenue Growth to $13.5 Billion in Q3 2025
Day One Biopharmaceuticals, Inc.Day One Biopharmaceuticals Reports Q3 2025 Financial Results with Increased Product Revenue but Declining Profitability
ONE Gas, Inc.ONE Gas Reports 11% Revenue Growth to $379.1 Million in Latest Quarter
IDEAYA Biosciences, Inc.IDEAYA Biosciences Reports $207.8M Collaboration Revenue and $119.2M Net Income for Q3 2025
Corvus Pharmaceuticals, Inc.Corvus Pharmaceuticals Reports $10.2 Million Net Loss, Sees Improvement in Financial Position
SHORE BANCSHARES INCShore Bancshares Reports 28.2% Increase in Net Income for Q3 2025
AMICUS THERAPEUTICS, INC.Amicus Therapeutics Reports 19.4% Increase in Quarterly Net Product Sales
VERTEX PHARMACEUTICALS INC / MAVertex Pharmaceuticals Reports $3.1 Billion Revenue in Q3 2025, Driven by Cystic Fibrosis Treatment
FORMFACTOR INCFormFactor Reports Revenue and Net Income Decline in Q3 Fiscal 2025
Sixth Street Specialty Lending, Inc.Sixth Street Specialty Lending Reports Q3 2025 Financial Results with Decrease in Investment Income
PERDOCEO EDUCATION CorpPerdoceo Education Corporation Reports 24.8% Revenue Growth to $211.9 Million in Latest Quarter
DOUGLAS DYNAMICS, INCDouglas Dynamics Reports Revenue Growth but Decline in Net Income for Q3 2025
ADT Inc.ADT Inc. Reports 4.4% Revenue Growth to $1.298 Billion in Q3 2025
BIOCRYST PHARMACEUTICALS INCBioCryst Pharmaceuticals Reports 36% Revenue Growth and Net Income Turnaround in Q3 2025
Carlyle Secured Lending, Inc.Carlyle Secured Lending Reports 19% Increase in Total Investment Income for Q3 2025